thiazolidines has been researched along with Hepatoblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, JC; Aye, JM; Beierle, EA; Bownes, LV; Marayati, R; Quinn, CH; Stafman, LL; Stewart, JE; Willey, CD; Williams, AP; Yoon, KJ | 1 |
1 other study(ies) available for thiazolidines and Hepatoblastoma
Article | Year |
---|---|
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; Gene Expression; Hepatoblastoma; Humans; Liver Neoplasms; Mice; Neoplastic Stem Cells; Phenotype; Proto-Oncogene Proteins c-pim-1; Thiazolidines; Xenograft Model Antitumor Assays | 2021 |